• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肾移植术后儿童的循环钙化抑制剂与血管特性

Circulating calcification inhibitors and vascular properties in children after renal transplantation.

作者信息

van Summeren Marieke J H, Hameleers Jeroen M, Schurgers Leon J, Hoeks Arnold P G, Uiterwaal Cuno S P M, Krüger Thilo, Vermeer Cees, Kuis Wietse, Lilien Marc R

机构信息

Department of Pediatric Immunology, University Medical Centre Utrecht, Lundlaan 6, Room KE.04.133.1, 3584 EA Utrecht, The Netherlands.

出版信息

Pediatr Nephrol. 2008 Jun;23(6):985-93. doi: 10.1007/s00467-007-0743-4.

DOI:10.1007/s00467-007-0743-4
PMID:18286307
Abstract

Pediatric transplant patients are known to have vascular abnormalities. The calcification inhibitors matrix Gla protein (MGP) and fetuin-A play an important role in the pathophysiology of vascular calcification. In the cross-sectional study reported here, we examined the circulating levels of fetuin-A and MGP in children after renal transplantation compared to healthy children and the association of these factors with vascular properties of the carotid artery. Levels of MGP and fetuin-A together with vascular properties of the carotid artery were determined in 29 pediatric renal transplant recipients and 54 healthy controls. The level of fetuin-A was decreased in the transplant group relative to the control group (P=0.005), whereas the level of MGP (both non-phosphorylated MGP and non-carboxylated MGP) did not differ between groups. The intima-media thickness (P<0.001) and the elasticity (P=0.002) of the carotid artery were significantly increased in children after renal transplantation compared to healthy children. No associations between vascular parameters and calcification inhibitors were found in either group. Circulating levels of MGP and fetuin-A could not be identified as independent predictors of vascular stiffness or other carotid artery parameters in pediatric renal transplant recipients. Future prospective studies in pediatric ESRD and transplant patients are needed to learn more about the role of calcification inhibitors in relation to the prevention of vascular damage.

摘要

已知小儿移植患者存在血管异常。钙化抑制剂基质Gla蛋白(MGP)和胎球蛋白-A在血管钙化的病理生理学中起重要作用。在本文报道的横断面研究中,我们检测了肾移植术后儿童与健康儿童相比循环中胎球蛋白-A和MGP的水平,以及这些因素与颈动脉血管特性的相关性。测定了29例小儿肾移植受者和54例健康对照者的MGP和胎球蛋白-A水平以及颈动脉的血管特性。与对照组相比,移植组胎球蛋白-A水平降低(P = 0.005),而两组间MGP(非磷酸化MGP和非羧化MGP)水平无差异。与健康儿童相比,肾移植术后儿童的颈动脉内膜中层厚度(P < 0.001)和弹性(P = 0.002)显著增加。两组中均未发现血管参数与钙化抑制剂之间存在关联。在小儿肾移植受者中,循环中MGP和胎球蛋白-A水平不能被确定为血管僵硬度或其他颈动脉参数的独立预测因子。需要对小儿终末期肾病和移植患者进行未来的前瞻性研究,以进一步了解钙化抑制剂在预防血管损伤方面的作用。

相似文献

1
Circulating calcification inhibitors and vascular properties in children after renal transplantation.肾移植术后儿童的循环钙化抑制剂与血管特性
Pediatr Nephrol. 2008 Jun;23(6):985-93. doi: 10.1007/s00467-007-0743-4.
2
The circulating calcification inhibitors, fetuin-A and osteoprotegerin, but not matrix Gla protein, are associated with vascular stiffness and calcification in children on dialysis.循环钙化抑制剂胎球蛋白-A和骨保护素,而非基质Gla蛋白,与接受透析治疗的儿童的血管僵硬和钙化有关。
Nephrol Dial Transplant. 2008 Oct;23(10):3263-71. doi: 10.1093/ndt/gfn226. Epub 2008 May 7.
3
Renal osteodystrophy: alpha-Heremans Schmid glycoprotein/fetuin-A, matrix GLA protein serum levels, and bone histomorphometry.肾性骨营养不良:α-赫里曼斯·施密德糖蛋白/胎球蛋白-A、基质γ-羧基谷氨酸蛋白血清水平与骨组织形态计量学
Am J Kidney Dis. 2006 Jul;48(1):106-13. doi: 10.1053/j.ajkd.2006.03.083.
4
Role of calcification inhibitors in the pathogenesis of vascular calcification in chronic kidney disease (CKD).钙化抑制剂在慢性肾脏病(CKD)血管钙化发病机制中的作用。
Kidney Int. 2005 Jun;67(6):2295-304. doi: 10.1111/j.1523-1755.2005.00333.x.
5
Immunohistochemical localization and mRNA expression of matrix Gla protein and fetuin-A in bone biopsies of hemodialysis patients.血液透析患者骨活检中基质Gla蛋白和胎球蛋白-A的免疫组化定位及mRNA表达
Virchows Arch. 2009 Mar;454(3):263-71. doi: 10.1007/s00428-008-0724-4. Epub 2009 Jan 17.
6
Gla-rich protein acts as a calcification inhibitor in the human cardiovascular system.载脂蛋白甘氨酸-rich 蛋白在人体心血管系统中充当着钙化抑制剂。
Arterioscler Thromb Vasc Biol. 2015 Feb;35(2):399-408. doi: 10.1161/ATVBAHA.114.304823. Epub 2014 Dec 23.
7
Correlation of serum Klotho, fetuin-A, and MGP levels with coronary artery calcification in maintenance hemodialysis patients.维持性血液透析患者血清 Klotho、胎球蛋白-A 和基质 Gla 蛋白水平与冠状动脉钙化的相关性。
Clinics (Sao Paulo). 2024 Jul 31;79:100417. doi: 10.1016/j.clinsp.2024.100417. eCollection 2024.
8
Serum levels of calcification inhibitors in patients with intracerebral hemorrhage.脑出血患者血清中的钙化抑制剂水平。
Int J Neurosci. 2012 May;122(5):227-32. doi: 10.3109/00207454.2011.642039. Epub 2011 Dec 22.
9
Analysis of calcifications in patients with coral reef aorta.珊瑚礁样主动脉患者钙化的分析。
Ann Vasc Surg. 2010 Apr;24(3):408-14. doi: 10.1016/j.avsg.2009.11.006. Epub 2010 Feb 7.
10
Circulating matrix Gla protein: a potential tool to identify minor carotid stenosis with calcification in a risk population.循环基质 Gla 蛋白:在风险人群中识别伴钙化的轻度颈动脉狭窄的潜在工具。
Clin Chem Lab Med. 2013 May;51(5):1115-23. doi: 10.1515/cclm-2012-0329.

引用本文的文献

1
Circulating calcification inhibitors are associated with arterial damage in pediatric patients with primary hypertension.循环钙化抑制剂与原发性高血压儿科患者的动脉损伤有关。
Pediatr Nephrol. 2021 Aug;36(8):2371-2382. doi: 10.1007/s00467-021-04957-5. Epub 2021 Feb 18.
2
The association between cardiac valvular calcification and fetuin-A levels in kidney transplant recipients.心脏瓣膜钙化与肾移植受者胎球蛋白-A 水平的关系。
Clin Exp Nephrol. 2019 Oct;23(10):1250-1256. doi: 10.1007/s10157-019-01761-2. Epub 2019 Jun 27.
3
Cardiovascular complications in children with chronic kidney disease.

本文引用的文献

1
Subclinical vitamin K deficiency in hemodialysis patients.血液透析患者的亚临床维生素K缺乏症
Am J Kidney Dis. 2007 Mar;49(3):432-9. doi: 10.1053/j.ajkd.2006.11.041.
2
Serum levels of calcification inhibition proteins and coronary artery calcium score: comparison between transplantation and dialysis.血清钙化抑制蛋白水平与冠状动脉钙化积分:移植与透析的比较
Am J Nephrol. 2007;27(1):75-83. doi: 10.1159/000099095. Epub 2007 Jan 26.
3
Molecular mechanisms mediating vascular calcification: role of matrix Gla protein.介导血管钙化的分子机制:基质Gla蛋白的作用
儿童慢性肾脏病的心血管并发症。
Nat Rev Nephrol. 2011 Sep 13;7(11):642-9. doi: 10.1038/nrneph.2011.116.
4
Serum fetuin-A levels are associated with vascular calcifications and predict cardiovascular events in renal transplant recipients.血清胎球蛋白-A 水平与血管钙化有关,并可预测肾移植受者的心血管事件。
Clin J Am Soc Nephrol. 2011 May;6(5):974-85. doi: 10.2215/CJN.06150710. Epub 2011 Apr 28.
5
CKD-MBD after kidney transplantation.肾移植后的 CKD-MBD。
Pediatr Nephrol. 2011 Dec;26(12):2143-51. doi: 10.1007/s00467-011-1829-6. Epub 2011 Mar 11.
6
Increased intima-media thickness of the carotid artery in childhood: a systematic review of observational studies.儿童颈动脉硬化内膜中层厚度增加:观察性研究的系统评价。
Eur J Pediatr. 2011 Jun;170(6):719-29. doi: 10.1007/s00431-010-1328-y. Epub 2010 Oct 27.
7
Cardiovascular disease in CKD in children: update on risk factors, risk assessment, and management.儿童慢性肾脏病中的心血管疾病:危险因素、风险评估及管理的最新进展
Am J Kidney Dis. 2009 Aug;54(2):345-60. doi: 10.1053/j.ajkd.2009.04.027.
Nephrology (Carlton). 2006 Oct;11(5):455-61. doi: 10.1111/j.1440-1797.2006.00660.x.
4
Coronary artery calcifications in children with end-stage renal disease.终末期肾病患儿的冠状动脉钙化
Pediatr Nephrol. 2006 Oct;21(10):1426-33. doi: 10.1007/s00467-006-0159-6. Epub 2006 Jul 4.
5
Matrix GLA protein gene polymorphisms: clinical correlates and cardiovascular mortality in chronic kidney disease patients.基质γ-羧基谷氨酸蛋白基因多态性:慢性肾脏病患者的临床关联及心血管死亡率
Am J Nephrol. 2005 Nov-Dec;25(6):548-52. doi: 10.1159/000088809. Epub 2005 Oct 5.
6
Biology of vascular calcification in renal disease.
Nephron Exp Nephrol. 2005;101(4):e134-8. doi: 10.1159/000087578. Epub 2005 Aug 19.
7
Multifunctional roles for serum protein fetuin-a in inhibition of human vascular smooth muscle cell calcification.血清蛋白胎球蛋白-A在抑制人血管平滑肌细胞钙化中的多功能作用。
J Am Soc Nephrol. 2005 Oct;16(10):2920-30. doi: 10.1681/ASN.2004100895. Epub 2005 Aug 10.
8
Novel conformation-specific antibodies against matrix gamma-carboxyglutamic acid (Gla) protein: undercarboxylated matrix Gla protein as marker for vascular calcification.新型抗基质γ-羧基谷氨酸(Gla)蛋白构象特异性抗体:未羧化基质Gla蛋白作为血管钙化的标志物
Arterioscler Thromb Vasc Biol. 2005 Aug;25(8):1629-33. doi: 10.1161/01.ATV.0000173313.46222.43. Epub 2005 Jun 16.
9
Associations of serum fetuin-A with malnutrition, inflammation, atherosclerosis and valvular calcification syndrome and outcome in peritoneal dialysis patients.血清胎球蛋白-A与腹膜透析患者营养不良、炎症、动脉粥样硬化及瓣膜钙化综合征的关联及预后
Nephrol Dial Transplant. 2005 Aug;20(8):1676-85. doi: 10.1093/ndt/gfh891. Epub 2005 May 17.
10
Role of calcification inhibitors in the pathogenesis of vascular calcification in chronic kidney disease (CKD).钙化抑制剂在慢性肾脏病(CKD)血管钙化发病机制中的作用。
Kidney Int. 2005 Jun;67(6):2295-304. doi: 10.1111/j.1523-1755.2005.00333.x.